Celgene
Discovering innovative medicines
- B2B
- Has physical offices
- Manufacturing
- Multi-product
- Sales-led purchase
About Celgene
Leading biopharma company producing innovative medicines for patients with serious diseases, specializing in cancer treatment and other advanced therapies
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
- Headquarters
- Summit, New Jersey, United States
- Revenue
- $206M – $1.6BTamtam estimate
- Website
- bms.com
- linkedin.com/company/celgene
Celgene in the news
- Celgene Fails to Fend Off Antitrust Claims in Pay-for-Delay Suit
A federal judge allowed an antitrust pay-for-delay lawsuit against Celgene Corp. and Natco Pharma Ltd. to proceed, concerning a settlement that allegedly delayed a generic blood cancer drug and kept prices high.
- Bristol-Myers, Natco And More Can't Ditch Cancer Drug MDL
A New Jersey federal judge did not dismiss an antitrust lawsuit against Bristol-Myers Squibb, Natco Pharma, and other companies regarding Celgene's cancer drug Revlimid, finding 'pay-for-delay' claims plausible.
- Celgene, Teva, others must face US antitrust claims over Revlimid, judge rules
A US judge ruled that Celgene, Teva, and other companies must face antitrust claims for allegedly monopolizing the Revlimid market.
- Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
Bristol Myers Squibb secured accelerated FDA approval for Zenbexus, a multiple myeloma drug acquired from Celgene, demonstrating superior efficacy and projected to achieve over $1 billion in sales by 2031.
- What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?
A federal appeals court reinstated a US$6.7 billion lawsuit against Bristol Myers Squibb concerning its Celgene acquisition, alleging delayed FDA approvals to avoid payouts.
Celgene at a glance
Celgene is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Summit, New Jersey, United States.
Celgene has 1,001–5,000 employees.
Celgene's revenue is $206M – $1.6B (Tamtam estimate).
Selling to companies like Celgene?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies